These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35488237)

  • 1. Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments.
    Sekino N; Selim M; Shehadah A
    J Neuroinflammation; 2022 Apr; 19(1):101. PubMed ID: 35488237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
    Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
    J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment.
    Pan S; Lv Z; Wang R; Shu H; Yuan S; Yu Y; Shang Y
    Oxid Med Cell Longev; 2022; 2022():1328729. PubMed ID: 36062193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
    Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
    Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Understanding of Long-Term Cognitive Impairment After Sepsis.
    Li Y; Ji M; Yang J
    Front Immunol; 2022; 13():855006. PubMed ID: 35603184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.
    Paris D; Ait-Ghezala G; Bachmeier C; Laco G; Beaulieu-Abdelahad D; Lin Y; Jin C; Crawford F; Mullan M
    J Biol Chem; 2014 Dec; 289(49):33927-44. PubMed ID: 25331948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats.
    Shi C; Yi D; Li Z; Zhou Y; Cao Y; Sun Y; Chui D; Guo X
    Behav Brain Res; 2017 Mar; 322(Pt A):167-176. PubMed ID: 28115220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.
    Kim HJ; Park S; Cho H; Jang YK; San Lee J; Jang H; Kim Y; Kim KW; Ryu YH; Choi JY; Moon SH; Weiner MW; Jagust WJ; Rabinovici GD; DeCarli C; Lyoo CH; Na DL; Seo SW
    JAMA Neurol; 2018 Aug; 75(8):999-1007. PubMed ID: 29799981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment.
    Singh A; Ansari VA; Mahmood T; Ahsan F; Wasim R; Shariq M; Parveen S; Maheshwari S
    Drug Res (Stuttg); 2023 Jun; 73(5):247-250. PubMed ID: 36889338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Secretase Pathway in Long-term Brain Inflammation and Cognitive Impairment in an Animal Model of Severe Sepsis.
    Michelon C; Michels M; Abatti M; Vieira A; Borges H; Dominguini D; Barichello T; Dal-Pizzol F
    Mol Neurobiol; 2020 Feb; 57(2):1159-1169. PubMed ID: 31701437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
    Tosun D; Demir Z; Veitch DP; Weintraub D; Aisen P; Jack CR; Jagust WJ; Petersen RC; Saykin AJ; Shaw LM; Trojanowski JQ; Weiner MW;
    Alzheimers Dement; 2022 Jul; 18(7):1370-1382. PubMed ID: 34647694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
    Deane R; Zlokovic BV
    Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Blood-Brain Barrier in Alzheimer's Disease.
    Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
    J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein attenuates amyloid-beta-induced cognitive impairment in rats by modulation of hippocampal synaptotoxicity and hyperphosphorylation of Tau.
    Petry FDS; Hoppe JB; Klein CP; Dos Santos BG; Hözer RM; Bifi F; Matté C; Salbego CG; Trindade VMT
    J Nutr Biochem; 2021 Jan; 87():108525. PubMed ID: 33065257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Spotorno N; Strandberg O; Vis G; Stomrud E; Nilsson M; Hansson O
    Brain; 2023 Apr; 146(4):1602-1614. PubMed ID: 36130332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
    Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
    Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate.
    Lam S; Petit F; Hérard AS; Boluda S; Eddarkaoui S; Guillermier M; ; Buée L; Duyckaerts C; Haïk S; Picq JL; Dhenain M
    Acta Neuropathol Commun; 2021 Oct; 9(1):165. PubMed ID: 34641980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.
    Bhargavan B; Woollard SM; McMillan JE; Kanmogne GD
    Mol Neurodegener; 2021 Nov; 16(1):78. PubMed ID: 34809709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.